 |
|
|
| |
Ledipasvir/sofosbuvir for 12 Weeks in Patients Coinfected With HCV and hiv-1: ION-4
|
| |
| |
Reported by Jules Levin
IAS 2015, July 19-22, 2015, Vancouver
8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 19-22, Vancouver, Canada BC
Curtis Cooper1, Susanna Naggie2,Michael Saag3, Luisa M. Stamm4, Jenny C. Yang4, Phillip S. Pang4, John G. McHutchison4, Douglas Dieterich5, Mark Sulkowski6
1 University of Ottawa, 2Duke Clinical Research Institute, Durham, NC; The Ottawa Hospital, Ottawa, ON; 3University of Alabama at Birmingham, Birmingham, AL,4Gilead Sciences, Inc., Foster City, CA; 5Icahn School of Medicine at Mount Sinai, New York, NY; 6Johns Hopkins University School of Medicine, Baltimore, MD
Webcast:
https://www.youtube.com/watch?v=TdY2bJTFajQ
|
| |
|
|
|
|
|
